Less pain more gain: venBio and other VCs make great returns on migraine drugs

Biotech VCs have played a crucial role in developing medicines for the disorder before selling them to big pharma, and they've realized exceptional returns while making a difference in patients' lives.

DealsDiversityHealthcareLife Sciences